K. Nakanishi

发表

A randomized phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer.

H. Uramoto, K. Yasumoto, T. Osaki, 2010, Anticancer research.

Treatment strategy for patients with surgically discovered N2 stage IIIA non-small cell lung cancer.

K. Yasumoto, I. Yoshino, H. Nakata, 1997, The Annals of thoracic surgery.

Lung cancer-reacting human recombinant antibody AE6F4: potential usefulness in the sputum cytodiagnosis.

K. Yasumoto, T. Suzuki, T. Yoshimatsu, 1996, Human antibodies and hybridomas.

The 14-3-3 protein as the antigen for lung cancer-associated human monoclonal antibody AE6F4.

T. Yoshimatsu, S Hashizume, K Mochizuki, 1994, Human antibodies and hybridomas.

Phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel in patients with completely resected non-small cell lung cancer.

H. Uramoto, K. Yasumoto, A. Uchiyama, 2005, Anticancer research.

Increased levels of serum intercellular adhesion molecule-1 (ICAM-1) in patients with non-small cell lung cancer.

T. Mitsudomi, T. Oyama, K. Sugio, 1996, Surgical oncology.

Effects of interleukin-12 on in vitro culture with interleukin-2 of regional lymph node lymphocytes from lung cancer patients

K. Yasumoto, I. Yoshino, M. Takenoyama, 1996, Cancer Immunology, Immunotherapy.

Elevated expression levels of the 14-3-3 family of proteins in lung cancer tissues.

K. Yasumoto, T. Honjoh, M. Kato, 1997, Human antibodies.

A Wien Filter Electron Energy Loss Spectrometer for Transmission Electron Microscopy

K. Tsuno, M. Kato, K. Nakanishi, 1990 .